Antonietta Morrica
University of Pisa
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Antonietta Morrica.
Journal of General Virology | 1997
Fabrizio Maggi; Claudia Fornai; Maria Linda Vatteroni; Massimo Giorgi; Antonietta Morrica; Mauro Pistello; G. Cammarota; Santino Marchi; P. Ciccorossi; A. Bionda; Mauro Bendinelli
Hepatitis C virus (HCV) exists in vivo as a highly variable mixture of closely related genomes (quasispecies), but the pathogenetic significance of such heterogeneity is still largely unknown. To investigate this issue, we compared the composition of HCV quasispecies found in the liver, peripheral blood mononuclear cells (PBMC) and plasma of ten patients by single-strand conformation polymorphism analysis of the E2/NS1 region and sequencing of the variants detected. We found considerable quasispecies differences between the liver and PBMC in all the patients, involving variant numbers, relative quantities and relative electrophoretic mobilities, but no apparent tissue-specific trend. Genome variants present in the liver and/or PBMC were not detected in the corresponding plasma samples, while certain HCV variants were present only in plasma. No dominant amino acids or amino acid pattern characteristic of variants present solely in the PBMC were detected in the E2/NS1 region sequenced.
The Journal of Infectious Diseases | 1999
Fabrizio Maggi; Claudia Fornai; Antonietta Morrica; Francesca Casula; Maria Linda Vatteroni; Santino Marchi; P. Ciccorossi; Lucrezia Riente; Mauro Pistello; Mauro Bendinelli
The pathogenic potential of the newly discovered TT virus (TTV) is currently a matter of conjecture. Its presence was investigated in the serum of 660 patients, by polymerase chain reaction. TTV was detected in 50% of 221 patients with unselected pathologies, and no significant differences related to age, sex, or organ disease were noted. TTV was present at a significantly higher rate in hemophiliacs (73%) and at lower rates in patients with cirrhosis (30%) and rheumatoid arthritis (28%). Patients with other liver diseases, systemic lupus erythematosus, or psoriasis or receiving hemodialysis had rates of infection similar to those in unselected patients. TTV-positive patients treated with interferon-alpha for underlying type C hepatitis showed no appreciable changes of TTV viremia levels. Type 1b was by far the most frequent viral genotype (92%), followed by types 2c (5%) and 1a (3%).
Journal of NeuroVirology | 1999
Fabrizio Maggi; Massimo Giorgi; Claudia Fornai; Antonietta Morrica; Maria Linda Vatteroni; Mauro Pistello; Gabriele Siciliano; Andrea Nuccorini; Mauro Bendinelli
Hepatitis C virus (HCV) is a leading cause of liver damage and has also been implicated in extrahepatic pathologies. We examined for HCV RNA paired CSF and plasma samples from 12 viremia positive patients using PCR. The CSF from 5/5 HIV-infected patients and 5/7 HIV-negative patients were HCV RNA positive. Branched DNA analysis showed that HCV loads in CSF were much lower than in plasma. Several HCV-positive CSF showed no evidence of blood contamination, impaired blood-brain barrier, or intrathecal IgG production. Comparison of HCV quasispecies in three sets of samples suggested that the virus in CSF was of plasma origin.
Journal of Medical Virology | 2001
Mauro Pistello; Antonietta Morrica; Fabrizio Maggi; Maria Linda Vatteroni; Giulia Freer; Claudia Fornai; Francesca Casula; Santino Marchi; P. Ciccorossi; Paolo Rovero; Mauro Bendinelli
TT virus (TTV) infection is extremely widespread in the general population. A sensitive real‐time PCR assay was developed that quantitated accurately the most prevalent TTV genotypes in Italy. When used to test 217 individuals for TTV viraemia, the overall prevalence was 94%. Viraemia levels varied widely amongst individual subjects, with no major differences related to gender or age. The highest TTV titres were in haemophiliacs and in patients with non‐A–E hepatitis, but they did not differ from the group with miscellaneous diseases. HIV‐ and HCV‐infected subjects and patients with primary liver diseases had TTV loads similar to those of healthy individuals. J. Med. Virol. 63:189–195, 2001.
Journal of Medical Virology | 1999
Fabrizio Maggi; Claudia Fornai; Antonietta Morrica; Maria Linda Vatteroni; Massimo Giorgi; Santino Marchi; P. Ciccorossi; Mauro Bendinelli; Mauro Pistello
In infected individuals, hepatitis C virus (HCV) exists as a variably complex population of related genetic variants known as quasispecies. The quasispecies of HCV were studied previously in 10 chronically infected patients by single‐strand conformation polymorphism analysis of a segment of the envelope gene E2/NS1 containing the hypervariable region 1 and it was found that certain variants (LC variants) were present both in the liver and in peripheral blood mononuclear cells (PBMC), others (L variants) were present in the liver but not in the PBMC, and still others (C variants) showed the opposite distribution. The sequence data obtained from nine such patients are reported, indicating that, within individual subjects, L and C variants are distinct phylogenetically. Results are described on the growth of HCV in stimulated healthy donor PBMC cultures supporting the concept that genetic divergence might stem, at least in part, from virus adaptation to growth in different cell types. This information may help to understand how HCV persists and produces disease in infected patients, especially with regard to extrahepatic pathology. J. Med. Virol. 57:57–63, 1999.
Journal of Virological Methods | 1999
Antonietta Morrica; Massimo Giorgi; Fabrizio Maggi; Claudia Fornai; Maria Linda Vatteroni; Santino Marchi; A. Ricchiuti; Guido Antonelli; Mauro Pistello; Mauro Bendinelli
The centrifugation-facilitated inoculation method was used to test 51 human and non-human cell lines for ability to support HCV replication. As determined by nested RT-PCR, one fifth of the cell lines tested were virus positive 15 days post inoculation suggesting that the centrifugation-facilitated inoculation is an efficient method for cell infection with HCV. However, virus production by infected cultures remained of low grade, thus showing that the unknown factors which limit HCV replication in vitro are not overcome by the procedure.
Journal of Medical Virology | 2001
Fabrizio Maggi; Claudia Fornai; Lucia Zaccaro; Antonietta Morrica; Maria Linda Vatteroni; Patrizia Isola; Santino Marchi; A. Ricchiuti; Mauro Pistello; Mauro Bendinelli
The Journal of Infectious Diseases | 2000
Antonietta Morrica; Fabrizio Maggi; Maria Linda Vatteroni; Claudia Fornai; Mauro Pistello; P. Ciccorossi; Elio Grassi; Andrea Gennazzani; Mauro Bendinelli
Journal of Clinical Microbiology | 1997
Fabrizio Maggi; Marialinda Vatteroni; Claudia Fornai; Antonietta Morrica; M Giorgi; Mauro Bendinelli; Mauro Pistello
Journal of Virological Methods | 1997
Marialinda Vatteroni; Fabrizio Maggi; Antonietta Morrica; Claudia Fornai; Massimo Giorgi; Mauro Pistello; Mauro Bendinelli